Mendenhall W M, Million R R, Cassisi N J
Int J Radiat Oncol Biol Phys. 1984 Dec;10(12):2223-30. doi: 10.1016/0360-3016(84)90227-x.
Eighty-one patients were treated with radical radiation therapy, with or without immediate neck dissection(s), for squamous cell carcinoma of the supraglottic larynx from October 1964 through May 1981. There is a 2-year minimum follow-up on all patients; 75/81 (93%) have a minimum 3-year follow-up, and 58/81 (72%) have at least a 5-year follow-up. Patients were staged according to the 1983 AJCC staging system. Patients were excluded from the local control analysis if they died less than 2 years from treatment with the primary site controlled. The initial local control rates and ultimate local control rates after surgical salvage of irradiation failures were as follows: T1, 11/12 (92%) and 12/12 (100%); T2, 20/26 (77%) and 23/26 (88%); T3, 9/14 (64%) and 11/14 (79%); and T4, 2/11 (18%) and 5/11 (45%). The incidence of severe complications was 3/81 (3.7%). The 5-year absolute and determinate survival rates by AJCC stage were as follows: I, 6/12 (50%) and 6/6 (100%); II, 5/6 (83%) and 5/5 (100%); III, 4/8 (50%) and 4/5 (80%); and IV, 6/32 (19%) and 6/26 (23%).
1964年10月至1981年5月期间,81例声门上型喉鳞状细胞癌患者接受了根治性放射治疗,部分患者同时或未同时立即行颈部清扫术。所有患者至少随访2年;75/81(93%)患者至少随访3年,58/81(72%)患者至少随访5年。患者根据1983年美国癌症联合委员会(AJCC)分期系统进行分期。如果患者在治疗后不到2年死亡且原发部位得到控制,则排除在局部控制分析之外。放疗失败后手术挽救后的初始局部控制率和最终局部控制率如下:T1期,11/12(92%)和12/12(100%);T2期,20/26(77%)和23/26(88%);T3期,9/14(64%)和11/14(79%);T4期,2/11(18%)和5/11(45%)。严重并发症发生率为3/81(3.7%)。根据AJCC分期的5年绝对生存率和确定生存率如下:I期,6/12(50%)和6/6(100%);II期,5/6(83%)和5/5(100%);III期,4/8(50%)和4/5(80%);IV期,6/32(19%)和6/26(23%)。